A double blinded randomized clinical trial of perioperative ketorolac 15 mg versus 30 mg, evaluated by visual analog score in orthopedic and ear-nose and throat patients
Objective: Ketorolac is a non-steroid anti-inflammatory drug for intravenous use, with analgesic and anti-inflammatory effects and known for its potent influence on moderate to severe postoperative pain. The literature has shown that 30mg i.v. perioperative ketorolac is efficient, well-tolerated and...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
GESDAV
2017-09-01
|
| Series: | Archives of Clinical and Experimental Surgery |
| Subjects: | |
| Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=227270 |